Xiaowen Zhang

17PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 25, 2026
IGF2BP3 promotes immune evasion and predicts poor prognosis in head and neck squamous cell carcinoma.

|Feb 09, 2026
Advances in organelle-targeted photosensitizer-mediated pyroptosis for photodynamic tumor therapy: overcoming immunological limitations.

Jianlei Xie, Yu Xiao, Baoxin Peng

|Oct 18, 2025
Adipose-derived stem cells inhibit dendritic cell migration by secreting tumor necrosis factor-α-stimulated gene 6 to improve the allogeneic skin transplantation survival rate in mice.

Julong Hu, Wenxu Peng, Yeltai Nurzat

|Aug 26, 2025
Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis.

Jianlei Xie, Baoxin Peng, Yu Xiao

|Mar 05, 2025
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps.

Mu Xian, Bing Yan, Xicheng Song

|Sep 13, 2024
B7-H3 promotes nasopharyngeal carcinoma progression by regulating CD8+ T cell exhaustion.

Zhaoen Ma, Gui Chen, Hao Li

Pageof 3

Frequent Collaborators

3 joint publications

Jianlei Xie

1 joint publications

Hongcheng Wu

1 joint publications

Juanxiu Liu

1 joint publications

Gui Chen